Buphenine

{{Drugbox | IUPAC_name = 4-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]propyl}phenol | image = Buphenine.svg

| tradename = | Drugs.com = International Drug Names | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =

| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =

| CAS_number = 447-41-6 | ATC_prefix = C04 | ATC_suffix = AA02 | ATC_supplemental = G02CA02 (WHO) | PubChem = 4567 | DrugBank = | ChemSpiderID = 4407 | UNII_Ref =  ^Y | UNII = 695DKH33EI | ChEMBL_Ref =  ^Y | ChEMBL = 114655

| C=19 | H=25 | N=1 | O=2 | molecular_weight = 299.41 g/mol | smiles = OC(c1ccc(O)cc1)C(NC(C)CCc2ccccc2)C }}

Buphenine (or nylidrin) is a β₂ adrenoreceptor agonist that acts as a vasodilator.